Year All2026202520242023202220212020201920182017201620152014 Jun 04, 2018 Soleno Therapeutics To Present Corporate Update at the BIO International Convention May 16, 2018 Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results May 14, 2018 Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome Apr 02, 2018 Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results Feb 20, 2018 Soleno Therapeutics Announces Successful End-of-Phase II Meeting with FDA for DCCR in Prader-Willi Syndrome Dec 12, 2017 Soleno Therapeutics Announces $15 Million Private Placement Dec 08, 2017 Soleno Therapeutics Announces Joint Venture Agreement for Development and Commercialization of CoSense Monitoring Technology Nov 22, 2017 Soleno Therapeutics to Present at the Piper Jaffray 29th Annual Healthcare Conference Nov 14, 2017 Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results Oct 23, 2017 Soleno Therapeutics Regains Compliance with NASDAQ Listing Requirements
May 16, 2018 Soleno Therapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
May 14, 2018 Soleno Therapeutics Announces Initiation of Phase III Clinical Trial of DCCR in Prader-Willi Syndrome
Apr 02, 2018 Soleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
Feb 20, 2018 Soleno Therapeutics Announces Successful End-of-Phase II Meeting with FDA for DCCR in Prader-Willi Syndrome
Dec 08, 2017 Soleno Therapeutics Announces Joint Venture Agreement for Development and Commercialization of CoSense Monitoring Technology
Nov 14, 2017 Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results